13G Filing: Broadfin Capital and Regulus Therapeutics Inc. (RGLS)

Page 10 of 10

Page 10 of 10 – SEC Filing

EXHIBIT A
Broadfin Capital, LLC is the relevant entity for which Kevin Kotler may be considered a control person.

Follow Regulus Therapeutics Inc. (NASDAQ:RGLS)

Page 10 of 10